Literature DB >> 19937551

Effects of alpha-asarone on the glutamate transporter EAAC1 in Xenopus oocytes.

Quanbao Gu1, Huiming Du, Chunhui Ma, Heike Fotis, Bin Wu, Chenggang Huang, Wolfgang Schwarz.   

Abstract

The major excitatory neurotransmitter transporter EAAC1 in the mammalian central nervous system is considered a possible target for Chinese herbal medicine. Extracts of Acorus tatarinowii (Schott) were tested for their effects on EAAC1 activity. XENOPUS oocytes with heterologously expressed EAAC1 were used as the model system. Rate of glutamate uptake was determined by means of the isotopic tracer technique. Glutamate-induced current was recorded under a two-electrode voltage clamp. As a highly effective component, alpha-asarone was identified. The rate of glutamate uptake was stimulated by 200 microM of alpha-asarone by about 15 %. In contrast, the same concentration reduced the EAAC1-mediated current by about 35 % at a holding potential of - 60 mV; half maximum inhibition was obtained at about 60 microM. Our experimental data suggest that both stimulation of glutamate uptake and inhibition of EAAC1-mediated current by alpha-asarone could contribute to reduced excitatory activity. Georg Thieme Verlag KG Stuttgart.New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937551     DOI: 10.1055/s-0029-1240613

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

1.  α-Asarone Attenuates Cognitive Deficit in a Pilocarpine-Induced Status Epilepticus Rat Model via a Decrease in the Nuclear Factor-κB Activation and Reduction in Microglia Neuroinflammation.

Authors:  Hui-Juan Liu; Xin Lai; Yan Xu; Jing-Kun Miao; Chun Li; Jing-Ying Liu; Yuan-Yuan Hua; Qian Ma; Qixiong Chen
Journal:  Front Neurol       Date:  2017-12-14       Impact factor: 4.003

Review 2.  Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling.

Authors:  Yan Liu; Shan Wang; Jun Kan; Jingzhi Zhang; Lisa Zhou; Yuli Huang; Yunlong Zhang
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 3.  GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment.

Authors:  Yilan Xu; Manna Zhao; Yuying Han; Heng Zhang
Journal:  Front Neurosci       Date:  2020-06-30       Impact factor: 4.677

4.  Identification of both GABAA receptors and voltage-activated Na(+) channels as molecular targets of anticonvulsant α-asarone.

Authors:  Ze-Jun Wang; Simon R Levinson; Liqin Sun; Thomas Heinbockel
Journal:  Front Pharmacol       Date:  2014-03-11       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.